Lamivudine bound in HBV polymerase

Drug Resistance

As treatment options for the management of Hepatitis B continue to grow, the clinician's challenge to manage drug selection in the face of single and multi-drug resistance is increasing daily.

Based on a dynamic global mutational database, SeqHepB has been designed to enable clinicians to manage their patients' treatment regime on an informed and accurate basis.

Genomic sequence analysis software within SeqHepB rapidly and accurately identifies those mutations and sub-mutations that lead to drug resistance and multi-drug resistance.